pristane has been researched along with Libman-Sacks Disease in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (2.76) | 18.2507 |
| 2000's | 26 (17.93) | 29.6817 |
| 2010's | 67 (46.21) | 24.3611 |
| 2020's | 48 (33.10) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, H; Hou, Y; Kong, W; Li, D; Li, J; Liang, J; Lu, L; Pan, Y; Wang, J; Wang, T; Xia, X | 1 |
| Boneva, GV; Bradyanova, SL; Chakarova, IV; Delimitreva, SM; Hadzhinesheva, VP; Kolarov, AI; Markova, MD; Mladenov, NJ; Nikolova, VP; Tchorbanov, AI; Zhivkova, RS | 1 |
| Guo, Y; He, Z; Hu, L; Li, F; Li, Q; Long, D; Long, H; Lu, L; Lu, Q; Wu, H; Yang, M; Zhao, M; Zhao, Z | 1 |
| Aschman, T; Biniaris Georgallis, SI; Schaffer, S; Staeheli, P; Triantafyllopoulou, A; Voll, RE | 1 |
| Takeuchi, O; Wakabayashi, A; Yoshinaga, M | 1 |
| Chapacais, GF; Freitas, EC; Karnopp, TE; Monticielo, OA; Rieger, A | 1 |
| Akaveka, L; Contreras, J; Forbess, LJ; Ishimori, M; Jefferies, CA; Laguna, DE; Montano, EN; Moore, RE; Santos, GL; Stripp, BR; Tumurkhuu, G; Venuturupalli, S; Wallace, DJ; Wang, Y | 1 |
| Gao, X; Hu, L; Jia, S; Lu, S; Song, Y; Zhao, M; Zheng, M | 1 |
| Dai, C; Hu, H; Hu, T; Jia, T; Meng, W; Pan, M; Sun, J; Wang, C; Wang, Q; Wang, X; Yin, Y; Zhu, J | 1 |
| Bartikoski, BJ; Busatto, A; de Souza Silva, JM; do Espírito Santo, RC; Dos Santos, M; Freitas, EC; Monticielo, OA; Xavier, RM | 1 |
| Chen, X; Johnson-Stephenson, TK; Li, J; Li, L; Wang, W; Wang, Y; Zen, K; Zhang, M; Zhu, D | 1 |
| Chantaravisoot, N; Kalpongnukul, N; Kumpunya, S; Leelahavanichkul, A; Pisitkun, P; Pisitkun, T; Thim-Uam, A; Thumarat, C | 1 |
| Alarcón-de-la-Lastra, C; Castejón, ML; de Sotomayor, MA; González, ML; Montoya, T; Ortega-Vidal, J; Sánchez-Hidalgo, M; Vazquéz-Román, MV | 1 |
| Ding, XH; Jin, YB; Qian, SH; Xiang, ST; Zhang, JJ; Zhang, MG | 1 |
| Chen, J; Jin, C; Qin, L; Wang, J; Wang, X; Xu, J; Yang, P; Yun, Y | 1 |
| Barati, M; Esmaeili, SA; Faridzadeh, A; Hoseini, S; Hoseinzadeh, A; Lavi Arab, F; Mahmoudi, A; Mahmoudi, M; Rezaeian, A; Rezaieyazdi, Z; Sadat Tabasi, N; Tavakol Afshari, J | 1 |
| Chen, J; He, Y; Li, H; Qiu, H; Shi, X; Song, S; Tian, W; Wen, C; Zhang, M | 1 |
| Clark, EA; Draves, KE; Elkon, KB; Giltiay, NV; Giordano, D; Kuley, R | 1 |
| Huang, C; Lu, Q; Yi, X; Zhao, M | 1 |
| Chen, XH; Liu, H; Mo, HY; Wang, YH; Wei, SR; Wu, WJ; Xu, J; Zhu, ZZ | 1 |
| Guo, M; Li, M; Liu, K; Liu, M; Liu, Y; Luo, H; Yang, Y; Zhang, H; Zhu, G; Zhu, Y; Zuo, X | 1 |
| Du, P; He, X; Hu, L; Jiang, L; Lu, Q; Wu, H; Zhao, M; Zhu, M | 1 |
| Chang, CH; Chen, CY; Chen, SY; Kuo, PY; Shiau, AL; Wang, CR; Wang, CT; Wu, CL | 1 |
| Chen, M; Li, LL; Luan, ZQ; Qu, Z; Tan, Y; Wang, H; Yu, F; Yu, XJ | 1 |
| Gao, S; Hua, C; Li, S; Qian, H; Wang, J; Wang, L; Wang, W; Xie, Y; Xing, Z; Ye, J; Yu, A; Yue, C; Zhang, T; Zhou, X | 1 |
| Huang, AF; Lan, YY; Li, R; Su, LC; Wang, YQ; Xu, WD; Yang, C | 1 |
| Chen, YC; Chou, YC; Hsieh, YT; Kuo, PY; Tsai, HW; Wang, CR; Yen, YT | 1 |
| Chen, W; He, X; Jin, S; Liu, J; Liu, W; Luo, Z; Wang, P; Wang, X; Yang, L; Zhang, T; Zhang, Y; Zhang, Z | 1 |
| Akbar, MIA; Bachnas, MA; Chouw, A; Dachlan, EG; Dekker, GA; Mudigdo, A; Purwanto, B; Sartika, CR; Sulistyowati, S; Widjiati, W | 1 |
| Dou, H; Hou, Y; Li, D; Li, J; Pan, Y; Qi, J; Wang, J; Xia, X | 1 |
| Bañuelos-Pineda, J; Corona-Meraz, FI; Floresvillar-Mosqueda, JF; Gutiérrez-Mercado, YK; Luciano-Jaramillo, J; Martín-Márquez, BT; Martínez-García, EA; Navarro-Hernández, RE; Pizano-Martínez, O; Sandoval-García, F; Vázquez-Del Mercado, M | 1 |
| Bhatnagar, A; Pannu, N | 3 |
| Jing, C; Song, Z; Yin, Y; Zhang, X; Zheng, Y | 1 |
| Chatthanathon, P; Hiengrach, P; Issara-Amphorn, J; Jaroonwitchawan, T; Leelahavanichkul, A; Palaga, T; Pisitkun, P; Somboonna, N; Surawut, S; Thim-Uam, A; Wilantho, A | 1 |
| Liu, A; Xiang, L; Xu, G | 1 |
| Abdelhamid, L; Cabana-Puig, X; Cecere, TE; Lee, J; LeRoith, T; Li, S; Li, Y; Luo, XM; Reilly, CM; Ross, AC; Sun, S; Swartwout, B; Wang, H; Werre, SR | 1 |
| Jin, R; Liu, C; Long, Y; Lu, S; Song, Y; Sun, X; Sun, XH; Yu, S; Zhang, Y | 1 |
| Alarcón-de-la-Lastra, C; Castejón, ML; González-Benjumea, A; Montoya, T; Sánchez-Hidalgo, M; Vázquez-Román, MV | 1 |
| Arditi, M; Blanco, LP; Chen, S; Crother, TR; De Los Santos, G; Ercan Laguna, D; Ishimori, M; Jefferies, CA; Kaplan, MJ; Lane, M; Markman, JL; Montano, EN; Shimada, K; Tumurkhuu, G; Wallace, DJ; Yamashita, M; Yu, JM | 1 |
| Alcantar, TM; Anderson, K; Austin, CD; Bacarro, N; Dunlap, D; Eastham, J; Ghilardi, N; Hackney, J; Heredia, J; Hui, J; Katewa, A; Lafkas, D; Lee, WP; Liang, J; Modrusan, Z; Paler-Martinez, A; Rairdan, XY; Suto, E | 1 |
| Jones, KE; Kalusche, WJ; McClung, DM; Ryan, MJ; Taylor, EB | 1 |
| Barnes, BJ; Chen, M; Clapp, WL; Cui, M; Lu, A; Meng, G; Niu, J; Wu, S | 1 |
| Gao, J; Liu, H; Liu, X; Song, X; Tang, K | 1 |
| Dai, X; Fang, X; Jin, L; Li, M; Li, X; Tao, J; Wang, Y; Xia, Y | 1 |
| Feng, J; Fu, W; Han, P; Hou, J; Li, J; Li, Z; Liu, C; Liu, F; Liu, Y; Ma, Y; Mu, R; Niu, J; Xu, D; Yang, G | 1 |
| Chaimovitz, C; Douvdevani, A; Haviv, YS; Mazar, J; Naamani, O; Riff, R | 1 |
| Han, S; Lu, L; Reeves, WH; Zhuang, H | 1 |
| Chen, M; Feng, Y; Jang, A; Sharp, R; Wang, J; Wang, JM | 1 |
| Cai, L; Qiu, Y; Shen, H; Shi, Q; Wang, J; Wang, Z; Zhu, Y | 1 |
| Han, S; Li, H; Reeves, WH; Shumyak, S; Wu, J; Yang, LJ; Zhuang, H | 1 |
| Blüml, S; Gessl, I; Jacobs, B; Kiss, A; Kozakowski, N; Leiss, H; Podesser, BK; Puchner, A; Salzberger, W; Smolen, JS; Stummvoll, GH | 1 |
| de Oliveira, MS; Freitas, EC; Monticielo, OA | 1 |
| Chen, B; Shi, J; Wang, S; Yang, S; Zhao, X | 1 |
| Athanassakis, I; Bakela, K; Batsou, P; Dimakopoulou, M; Manidakis, N | 1 |
| Han, S; Li, H; Reeves, WH; Shumyak, S; Wu, J; Xie, C; Yang, LJ; Zhuang, H | 1 |
| Hiramatsu, S; Hirashima, M; Katsuyama, E; Katsuyama, T; Kawabata, T; Matsumoto, Y; Niki, T; Sada, KE; Teshigawara, S; Wada, J; Watanabe, H; Watanabe, KS; Zeggar, S | 1 |
| Huang, B; Jiang, J; Liu, Y; Luo, B; Wang, Z; Zhang, Z; Zhu, W | 1 |
| Agdana, HM; Handono, K; Hasanah, D; Hermawan, HO; Kalim, H; Kawuningan, KB; Nur'aini, N; Pratama, MZ; Sari, DK | 1 |
| Alarcon-de-la-Lastra, C; Aparicio-Soto, M; Bermudez, B; Cardeno, A; Montserrat-de la Paz, S; Muriana, FJG; Sanchez-Hidalgo, M | 1 |
| Esmaeili, SA; Khorasani, S; Mahmoudi, M; Mardani, F; Rastin, M; Tabasi, N | 1 |
| Björkbacka, H; Contreras, J; Cunningham, K; Fernando, T; Forbess, L; Gabhann, JN; Ishimori, M; Jefferies, CA; Jin, M; Kearns, G; Kong, W; Kornfeld, H; McCarthy, EM; Molloy, ES; Montano, EN; Murphy, CC; Seo, JJ; Smith, S; Venuturupalli, S; Wallace, D; Weisman, MH; Widaa, A; Wu, PW | 1 |
| Li, YS; Xu, SP | 1 |
| Esmaeili, SA; Kalantari, MR; Khorasani, S; Lavi Arab, F; Mahmoudi, M; Mardani, F; Rastin, M; Tabasi, N | 1 |
| Chindamporn, A; Leelahavanichkul, A; Makjaroen, J; Palaga, T; Pisitkun, P; Surawut, S; Thim-Uam, A; Wongphoom, J | 1 |
| Huang, AF; Su, LC; Xu, WD | 1 |
| Cai, J; Chen, Y; Ji, P; Kang, Z; Liu, S; Liu, XN; Pan, M; Wang, S; Wang, Y; Yao, C; Zhang, M | 1 |
| Allegood, JC; Aparna, JS; Harikumar, KB; James, S; Lankadasari, MB; Li, QZ; Mohammed, S; Spiegel, S; Vineetha, NS | 1 |
| Botte, DAC; Carrasco, S; Catanozi, S; de Mello, SBV; Goldenstein-Schainberg, C; Lima, TM; Parra, ER; Peixoto, TV; Rodrigues, CM; Soriano, FG; Ugriumov, N | 1 |
| Amann, K; Daniel, C; Frey, S; Herrmann, M; Pirschel, W; Pohle, S; Schett, G; Starke, C; Urbonaviciute, V; Voll, RE | 1 |
| Bandur, T; Blüml, S; Leiss, H; Niederreiter, B; Schwarzecker, B; Smolen, JS; Steiner, G; Stummvoll, GH; Ulrich, W | 1 |
| Bonegio, R; Bossaller, L; Busto, P; Caffrey, DR; Chiang, PI; Fitzgerald, KA; Latz, E; Li, QZ; Marshak-Rothstein, A; Mohan, C; Rathinam, VA; Wespiser, AR | 1 |
| Hodgin, JB; Kahlenberg, JM; Kaplan, MJ; Reed, TJ; Tsuji, NM; Yalavarthi, S; Zhao, W | 1 |
| Akare, S; Bender, AT; Cao, Q; Ding, Y; Genest, M; Ishizaka, ST; Mackey, MF; Oestreicher, J; Wu, Y | 1 |
| Morel, L; Reeves, WH; Xu, Y; Zeumer, L | 1 |
| Botte, DA; de Mello, SB; Malheiros, DM; Noronha, IL; Peixoto, TV | 1 |
| Amarilyo, G; La Cava, A; Lourenço, EV; Shi, FD | 1 |
| Goilav, B; Herlitz, L; Pawar, RD; Putterman, C; Reeves, WH; Xia, Y; Zhuang, H | 1 |
| Han, S; Liu, C; Massini, J; Mathews, CE; Reeves, WH; Wang, H; Xu, Y; Yang, L; Zhuang, H | 1 |
| Du, Q; Furuhashi, K; Horinouchi, A; Kosugi, T; Maeda, K; Maruyama, S; Matsuo, S; Shi, Y; Tsuboi, N | 1 |
| Balazs, M; Caplazi, P; DeForge, L; Lee, WP; Lin, W; Lin, Z; Martin, F; McVay, S; Nguyen, A; Seshasayee, D; Sun, Y; Suto, E; Zarrin, AA | 1 |
| Bederman, AG; Coquery, CM; Erickson, LD; Hess, H; Lewis, JE; Loo, WM; Tung, KS; Wade, NS | 1 |
| Chen, HZ; Chen, Z; Gao, N; Li, MT; Luo, XF; Wang, ZL; Xu, D; Zeng, XF; Zhang, LL; Zhou, S | 1 |
| Agerberth, B; Amann, K; Barron, AE; Borràs, ÈB; Hahn, J; Hoffmann, MH; Hueber, AJ; Ipseiz, N; Kienhöfer, D; Lang, SC; Reinwald, C; Schett, G; Schubert, I; Sjöwall, C | 1 |
| Cascalho, M; Clark, KL; Kahlenberg, JM; Morse, MD | 1 |
| Goerke, B; Kluger, MA; Luig, M; Melderis, S; Meyer, MC; Meyer-Schwesinger, C; Nosko, A; Panzer, U; Stahl, RA; Steinmetz, OM; Tiegs, G; Turner, JE; Wegscheid, C | 1 |
| Brohawn, P; Harley, JB; Higgs, BW; Huang, X; Jallal, B; Jia, Q; Liu, Z; Meng, Y; Qu, B; Shen, N; Tang, Y; Wang, Y; Xiao, C; Yao, Y; Zhou, S | 1 |
| Ma, H; Wan, S; Xia, CQ | 1 |
| Choi, HS; Han, S; Lee, P; Li, Y; Reeves, WH; Sun, Y; Vidal, O; Wilson, JC; Xu, Y; Yang, LJ; Zhuang, H | 1 |
| Botto, M; Carlucci, F; Cook, HT; Donatien, P; Ishaque, A; Ling, GS; Sandison, A; Szajna, M | 1 |
| Bender, AT; Caldwell, R; Chen, YY; Fu, K; Genest, M; Grenningloh, R; Head, J; Koehler, U; Liu-Bujalski, L; Morandi, F; Okitsu, SL; Pereira, A; Samy, E; Tian, H; Wu, Y; Xu, D | 1 |
| Cui, B; Gao, X; Jiao, Y; Liu, X; Xu, J; Zhao, Y | 1 |
| Chan, A; Han, S; Hoffmann, MH; Kienhöfer, D; Lee, P; Li, Y; Meyerholz, R; Reeves, WH; Rosadzinski, K; Rosner, D; Segal, M; Shumyak, S; Sobel, E; Xu, Y; Yang, LJ; Zhuang, H | 1 |
| Eitzman, DT; Guo, C; Hodgin, JB; Kleiman, K; Knight, JS; Wang, H; Wang, J | 1 |
| Han, S; Reeves, WH; Shumyak, S; Yang, LJ; Zhuang, H | 1 |
| He, J; Li, ZA; Liu, JF; Pan, XH; Pang, RQ; Ruan, GP; Yang, JY; Yao, X | 1 |
| La Cava, A; Liu, A; Lourenço, EV; Matarese, G | 1 |
| Chen, YC; Du, GH; Fang, JS; He, YY; Lin, YH; Wu, P; Yan, Y; Yang, SH; Zhang, HF | 1 |
| Abliz, P; An, L; Guo, Q; Li, H; Lu, A; Meng, G; Niu, J; Wan, N; Wu, S; Xue, G; Yang, G; Yao, X | 1 |
| Afaneh, A; Chatha, A; Han, S; Khaybullin, R; Lee, PY; Lu, L; Moldawer, L; Nacionales, D; Qi, X; Reeves, WH; Shumyak, S; Xie, C; Yang, LJ; Zhang, Y; Zhuang, H | 1 |
| Bradyanova, S; Chausheva, S; Chipinski, P; Herbáth, M; Kyurkchiev, D; Mihaylova, N; Prechl, J; Tchorbanov, AI | 1 |
| Gu, L; Li, X; Shen, J; Yang, L; Zhang, D | 1 |
| Akira, S; Barker, T; Kawai, T; Kellner, ES; Kelly-Scumpia, K; Kumagai, Y; Kumar, H; Lee, PY; Li, Y; Nacionales, D; Reeves, WH; Satoh, M; Takeuchi, O; van Rooijen, N; Weinstein, J; Yoshida, H | 1 |
| Albesiano, E; Chiorazzi, N; Kelly-Scumpia, KM; Lee, PY; Lyons, R; Nacionales, DC; Reeves, WH; Satoh, M; Weinstein, JS; Yan, XJ | 1 |
| Lee, PY; Lu, L; Reeves, WH; Satoh, M; Weinstein, JS | 1 |
| Fujimoto, M; Haas, KM; Ishiura, N; Matsushita, T; Nakashima, H; Okochi, H; Tedder, TF; Watanabe, R | 1 |
| Dimitrova, I; Gesheva, V; Mihaylova, N; Nikolova, K; Nikolova, M; Tchorbanov, A; Todorov, T | 1 |
| Si, JF; Wei, W; Yuan, DP; Zhou, LL | 1 |
| Akira, S; Hoi, A; Holdsworth, SR; Kitching, AR; O'Sullivan, KM; Odobasic, D; Ooi, JD; Steinmetz, OM; Summers, SA | 1 |
| Batten, M; Caplazi, P; Cook, MC; Cox, JH; Danilenko, DM; de Sauvage, FJ; Dengler, HS; Fulcher, DA; Ghilardi, N; King, C; Kljavin, NM; Ma, CS; Ramamoorthi, N; Tangye, SG; Wong, M | 1 |
| Chen, XJ; Ding, J; Li, HW; Li, JZ; Merim, B; Shen, H; Wang, SJ; Wang, Y; Zhang, Y | 1 |
| Bhatnagar, A; Das, P; Minhas, U | 1 |
| Bhatnagar, A; Das, P; Minhas, U; Minz, R | 1 |
| Han, S; Lee, PY; Li, SW; Li, Y; Liu, C; Mathews, CE; Moldawer, LL; Nacionales, DC; Reeves, WH; Satoh, M; Weinstein, J; Xu, Y; Yang, LJ; Zhuang, H | 1 |
| Barnes, BJ; Bi, X; Feng, D; Patel, P; Stone, RC; Yang, L | 1 |
| Herman, S; Herrmann, M; Hoffmann, MH; Holmdahl, R; Kny, A; Niederreiter, B; Pfatschbacher, J; Schorn, C; Steiner, G | 1 |
| Barnes, BJ; Bi, X; Feng, D; Stone, RC; Yang, L | 1 |
| Akaogi, J; Behney, KM; Kuroda, Y; Lorenson, TD; Mizutani, A; Nacionales, DC; Reeves, WH; Rosenbauer, RJ; Satoh, M; Yoshida, H | 1 |
| Akaogi, J; Behney, KM; Hirakata, M; Kuroda, Y; Mizutani, A; Nacionales, DC; Ono, N; Reeves, WH; Satoh, M; Yoshida, H | 1 |
| Akaogi, J; Kuroda, Y; Nacionales, DC; Reeves, WH; Satoh, M | 1 |
| Bigazzi, PE | 1 |
| Akaogi, J; Hirakata, M; Kuroda, Y; Mizutani, A; Nacionales, DC; Ono, N; Reeves, WH; Satoh, M; Shaheen, VM; Yamasaki, Y; Yoshida, H | 1 |
| Joyce, S; Parekh, VV; Singh, AK; Singh, RR; Van Kaer, L; Wang, CR; Wei, J; Yang, JQ | 1 |
| Calvani, N; Clynes, R; Croker, BP; Richards, HB | 1 |
| Ghetie, V; Pop, LM; Zhou, J | 1 |
| Calvani, N; Caricchio, R; Richards, HB; Silvestris, F; Sobel, ES; Tartaglia, P; Tucci, M | 1 |
| Akaogi, J; Kelly, KM; Kuroda, Y; Lee, PY; Li, Y; Nacionales, DC; Reeves, WH; Satoh, M; Sobel, E; Weinstein, JS; Zhuang, H | 1 |
| Cui, GM; Kan, B; Liu, G; Liu, W; Mao, YQ; Wei, YQ | 1 |
| Chae, BS; Park, JS; Shin, TY | 1 |
| Dong, X; Du, S; Oh, M; Singh, RR; Smith, DL; Voskuhl, RR | 1 |
| Anderson-Mahoney, P; Dahlgren, J; Kotlerman, J; Takhar, H; Tarr, J; Warshaw, R | 1 |
| Chae, BS; Shin, TY | 1 |
| Chowdhary, VR; David, CS; Grande, JP; Luthra, HS | 1 |
| Kelly-Scumpia, KM; Lee, PY; Lyons, R; Nacionales, DC; Reeves, WH; Satoh, M; Sobel, E; Weinstein, JS | 1 |
| Caricchio, R; Frisoni, L; Kang, SA; Madaio, M; McPhie, L; Monestier, M; Satoh, M | 1 |
| Butfiloski, E; Lee, PY; Li, Y; Moldawer, L; Nacionales, DC; Reeves, WH; Satoh, M; Scumpia, PO; van Rooijen, N; Weinstein, JS | 1 |
| Chae, BS; Eun, JS; Kim, DK; Leem, JY; Shin, TY; Yang, JH | 1 |
| Kanwar, YS; Kumar, A; Reeves, WH; Satoh, M | 1 |
| Reeves, WH; Satoh, M | 1 |
| Jennette, JC; Kanwar, YS; Okano, T; Reeves, WH; Richards, HB; Satoh, M | 1 |
| Jennette, JC; Reeves, WH; Richards, HB; Satoh, M; Shaheen, VM; Shaw, M; Yoshida, H | 1 |
| Naim, JO; Reeves, WH; Richards, HB; Satoh, M; Shaheen, VM; Shaw, M; Wooley, PH; Yoshida, H | 1 |
| Reap, EA; Reeves, WH; Richards, HB; Satoh, M; Shaw, M; Yoshida, H | 1 |
| Boyce, JG; Dajani, EZ; Davidson, EC; Scott, VF; Trotman, BW | 1 |
3 review(s) available for pristane and Libman-Sacks Disease
| Article | Year |
|---|---|
Pristane-induced lupus: considerations on this experimental model.
Topics: Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Terpenes | 2017 |
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
Topics: Animals; Autoantibodies; Disease Models, Animal; Humans; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Signal Transduction; snRNP Core Proteins; Terpenes | 2009 |
Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
Topics: Adjuvants, Immunologic; Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Freund's Adjuvant; Humans; Lupus Erythematosus, Systemic; Mice; Mineral Oil; Squalene; Terpenes; Vaccines | 2004 |
142 other study(ies) available for pristane and Libman-Sacks Disease
| Article | Year |
|---|---|
C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1
Topics: Adoptive Transfer; Adult; Animals; Apoptosis; Cell Differentiation; Cell Nucleus; Disease Models, Animal; Female; Forkhead Box Protein O1; Gene Expression Regulation; Gene Silencing; Humans; Imiquimod; Lectins, C-Type; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Middle Aged; Monocytes; Myeloid-Derived Suppressor Cells; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Receptors, Immunologic; Scavenger Receptors, Class E; Syk Kinase; Terpenes | 2021 |
Defective oogenesis in mice with pristane-induced model of systemic lupus.
Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Female; Humans; Lupus Erythematosus, Systemic; Metaphase; Mice; Mice, Inbred BALB C; Oogenesis; Pregnancy; Terpenes | 2021 |
AIM2 deficiency in B cells ameliorates systemic lupus erythematosus by regulating Blimp-1-Bcl-6 axis-mediated B-cell differentiation.
Topics: Adenoids; Animals; Antigens, CD19; Cell Differentiation; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Germinal Center; Humans; Immunity, Innate; Lupus Erythematosus, Systemic; Lymph Nodes; Memory B Cells; Mice; Positive Regulatory Domain I-Binding Factor 1; Proto-Oncogene Proteins c-bcl-6; Spleen; Terpenes | 2021 |
Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.
Topics: Animals; Immunity, Cellular; Immunity, Humoral; Interferon Lambda; Interferons; Leukocytes; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Receptors, Interferon; Terpenes | 2021 |
TANK prevents IFN-dependent fatal diffuse alveolar hemorrhage by suppressing DNA-cGAS aggregation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Biopsy; Disease Models, Animal; Disease Susceptibility; DNA; Hemorrhage; Immunity, Innate; Immunohistochemistry; Immunosuppressive Agents; Interferons; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Nucleotidyltransferases; Pulmonary Alveoli; Signal Transduction; Terpenes; Toll-Like Receptors | 2022 |
Higher IgG level correlated with vitamin D receptor in the hippocampus of a pristane-induced lupus model.
Topics: Animals; Female; Hippocampus; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Mice; Receptors, Calcitriol; Terpenes; Vitamin D | 2022 |
Neutrophils Contribute to ER Stress in Lung Epithelial Cells in the Pristane-Induced Diffuse Alveolar Hemorrhage Mouse Model.
Topics: Animals; Disease Models, Animal; Epithelial Cells; Extracellular Traps; Female; Hemorrhage; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Neutrophils; Pneumonia; Pulmonary Alveoli; Terpenes | 2022 |
Insufficient Iron Improves Pristane-Induced Lupus by Promoting Treg Cell Expansion.
Topics: Humans; Iron; Lupus Erythematosus, Systemic; T-Lymphocytes, Regulatory; Terpenes | 2022 |
UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
Topics: Animals; Autophagy; Cell Cycle Proteins; DNA; Fibroblasts; Interferon Type I; Interferon-beta; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Mice; Molecular Chaperones; Nucleotidyltransferases; Sequestosome-1 Protein | 2023 |
Vitamin D supplementation modulates autophagy in the pristane-induced lupus model.
Topics: Animals; Autophagy; Dietary Supplements; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Terpenes; Vitamin D | 2022 |
Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17
Topics: Animals; Anti-Inflammatory Agents; Arginase; Culture Media, Conditioned; Cytokines; Exosomes; Interleukin-17; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; MicroRNAs; Nitric Oxide Synthase Type II; Reactive Oxygen Species; T-Lymphocytes, Regulatory; Terpenes | 2022 |
cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus.
Topics: Animals; Autoantibodies; Disease Models, Animal; DNA; Inflammasomes; Inflammation; Lupus Erythematosus, Systemic; Macrophages; Mice; Nucleotidyltransferases | 2022 |
Oleocanthal supplemented diet improves renal damage and endothelial dysfunction in pristane-induced systemic lupus erythematosus in mice.
Topics: Animals; Cytokines; Diet; Dietary Supplements; Lupus Erythematosus, Systemic; Mice | 2023 |
Pristane cadmium chloride nanoemulsion accelerates the onset of systemic lupus erythematosus in a C57BL/6 mouse model.
Topics: Animals; Cadmium Chloride; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Terpenes | 2023 |
Pristane induced lupus mice as a model for neuropsychiatric lupus (NPSLE).
Topics: Animals; Chemokines; Cytokines; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Mice | 2023 |
Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Topics: Animals; Cytokines; Lupus Erythematosus, Systemic; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; T-Lymphocytes, Regulatory; Th17 Cells; Transforming Growth Factor beta | 2023 |
Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Foam Cells; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Mice; Myeloid Differentiation Factor 88; PPAR gamma; Toll-Like Receptor 9 | 2023 |
B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Dendritic Cells; Disease Models, Animal; Interleukin-4; Lupus Erythematosus, Systemic; Mice; Monocytes; Neutrophils; Toll-Like Receptor 7 | 2023 |
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus.
Topics: Animals; Feces; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Microbiota; RNA, Ribosomal, 16S | 2023 |
Role of CD19
Topics: Animals; Atherosclerosis; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; T-Lymphocytes, Regulatory; Th17 Cells | 2023 |
EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance.
Topics: Animals; Autoantibodies; Enhancer of Zeste Homolog 2 Protein; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Mice | 2023 |
Mivebresib alleviates systemic lupus erythematosus-associated diffuse alveolar hemorrhage via inhibiting infiltration of monocytes and M1 polarization of macrophages.
Topics: Animals; Hemorrhage; Lung Diseases; Lupus Erythematosus, Systemic; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Nuclear Proteins; Transcription Factors | 2023 |
Galectin-3 Mediates NETosis and Acts as an Autoantigen in Systemic Lupus Erythematosus-Associated Diffuse Alveolar Haemorrhage.
Topics: Animals; Autoantigens; Extracellular Traps; Galectin 3; Hemorrhage; Humans; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Neutrophils; Proteinuria | 2023 |
Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis.
Topics: Animals; Autoantibodies; Complement Factor H; Epitopes; Female; Humans; Immunoglobulin G; Immunologic Factors; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C | 2023 |
Agomir miRNA-150-5p alleviates pristane-induced lupus by suppressing myeloid dendritic cells activation and inflammation via TREM-1 axis.
Topics: Animals; Dendritic Cells; Inflammation; Lupus Erythematosus, Systemic; Mice; MicroRNAs; Triggering Receptor Expressed on Myeloid Cells-1 | 2023 |
SHP2: its association and roles in systemic lupus erythematosus.
Topics: Animals; Autoimmune Diseases; Biomarkers; Cytokines; Lupus Erythematosus, Systemic; Mice; Terpenes | 2023 |
Long noncoding RNA SNHG16 regulates TLR4-mediated autophagy and NETosis formation in alveolar hemorrhage associated with systemic lupus erythematosus.
Topics: Animals; Autophagy; Humans; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; RNA, Long Noncoding; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4 | 2023 |
Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
Topics: Animals; Autoantibodies; Cytokines; Disease Models, Animal; Humans; Imatinib Mesylate; Interferons; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Molecular Docking Simulation; NF-kappa B | 2023 |
Mesenchymal stem cell secretome ameliorates over-expression of soluble fms-like tyrosine kinase-1 (sFlt-1) and fetal growth restriction (FGR) in animal SLE model.
Topics: Abortion, Spontaneous; Animals; Biomarkers; Birth Weight; Female; Fetal Growth Retardation; Humans; Lupus Erythematosus, Systemic; Mesenchymal Stem Cells; Mice; Models, Animal; Placenta; Placenta Growth Factor; Pregnancy; Secretome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2023 |
Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
Topics: Animals; Antimalarials; Artemisinins; Carcinogens; Cellular Senescence; Female; Gene Expression Regulation; Heme Oxygenase-1; Lupus Erythematosus, Systemic; Membrane Proteins; Mice; Mice, Inbred BALB C; Myeloid-Derived Suppressor Cells; NF-E2-Related Factor 2; Terpenes | 2019 |
Downregulation of hippocampal NR2A/2B subunits related to cognitive impairment in a pristane-induced lupus BALB/c mice.
Topics: Animals; Cognitive Dysfunction; Disease Models, Animal; Down-Regulation; Female; Gene Expression; Hippocampus; Lipopolysaccharides; Lupus Erythematosus, Systemic; Maze Learning; Memory Disorders; Memory, Long-Term; Memory, Short-Term; Mice; Mice, Inbred BALB C; Receptors, N-Methyl-D-Aspartate; Terpenes | 2019 |
Combinatorial therapeutic effect of resveratrol and piperine on murine model of systemic lupus erythematosus.
Topics: Alkaloids; Animals; Autoantibodies; Benzodioxoles; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes; Treatment Outcome | 2020 |
Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Cytokines; Disease Models, Animal; Feasibility Studies; Female; Humans; Inflammation; Inflammation Mediators; Lipid Peroxidation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Oxidative Stress; Reactive Oxygen Species; Terpenes | 2020 |
Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
Topics: Adolescent; Animals; Disease Models, Animal; Female; Humans; Inflammation; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Progranulins; Terpenes | 2020 |
Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus.
Topics: Animals; beta-Glucans; Cytokines; Dextran Sulfate; Disease Models, Animal; Disease Progression; Feces; Female; Lupus Erythematosus, Systemic; Mice; Receptors, IgG; Terpenes | 2020 |
Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Topics: Animals; Autoantibodies; B-Lymphocytes; Cell Proliferation; Disease Models, Animal; Female; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice, Inbred BALB C; Signal Transduction; Spleen; Sulfonamides; Terpenes; Thiophenes; X-Box Binding Protein 1 | 2020 |
Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
Topics: Animals; Bacterial Translocation; Contraindications, Drug; Dendritic Cells; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Synergism; Dysbiosis; Female; Gastrointestinal Microbiome; Gene Expression Regulation; Glomerulonephritis; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA; RNA-Seq; Specific Pathogen-Free Organisms; Spleen; Terpenes; Tretinoin; Vitamin A | 2020 |
Prophylactic effect of resveratrol and piperine on pristane-induced murine model of lupus-like disease.
Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Cytokines; Disease Models, Animal; Female; Inflammation; Kidney; Lipid Peroxidation; Liver; Lung; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Oxidative Stress; Piperidines; Polyunsaturated Alkamides; Resveratrol; Terpenes | 2020 |
Correlation of the levels of DNA-binding inhibitor Id3 and regulatory T cells with SLE disease severity.
Topics: Animals; Autoantibodies; Case-Control Studies; Disease Models, Animal; Healthy Volunteers; Humans; Inhibitor of Differentiation Protein 1; Inhibitor of Differentiation Proteins; Lupus Erythematosus, Systemic; Mice, Knockout; Mice, Transgenic; Neoplasm Proteins; Severity of Illness Index; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Terpenes; Up-Regulation | 2020 |
Dietary oleuropein and its acyl derivative ameliorate inflammatory response in peritoneal macrophages from pristane-induced SLE mice via canonical and noncanonical NLRP3 inflammasomes pathway.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Inflammasomes; Iridoid Glucosides; Iridoids; Lupus Erythematosus, Systemic; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; NLR Family, Pyrin Domain-Containing 3 Protein; Olea; Phenols; Terpenes | 2020 |
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model.
Topics: Animals; Disease Models, Animal; DNA Damage; DNA Glycosylases; Inflammation; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Monocytes; Oxidation-Reduction; Skin; Terpenes | 2020 |
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
Topics: Animals; Chemokines; Cytokines; Dendritic Cells; Imidazoles; Interferon-alpha; Lupus Erythematosus, Systemic; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Mice, Knockout; Survival Rate; Terpenes; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2021 |
Hypertension and endothelial dysfunction in the pristane model of systemic lupus erythematosus.
Topics: Animals; Antibodies, Antinuclear; Arterial Pressure; Autoimmunity; Disease Models, Animal; Endothelium, Vascular; Female; Hypertension; Lupus Erythematosus, Systemic; Mice, Inbred C57BL; Neutrophils; Terpenes; Thymocytes; Vasodilation | 2021 |
Aim2 Couples With Ube2i for Sumoylation-Mediated Repression of Interferon Signatures in Systemic Lupus Erythematosus.
Topics: Animals; Disease Models, Animal; DNA-Binding Proteins; Female; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Sumoylation; Terpenes; Ubiquitin-Conjugating Enzymes | 2021 |
Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Dendritic Cells; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice, Inbred BALB C; Sirolimus; T-Lymphocytes, Helper-Inducer; Terpenes | 2021 |
Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; Arthritis, Rheumatoid; Chromones; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Humans; Immunoglobulins; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Proteinuria; Sulfonamides; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells | 2021 |
A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis.
Topics: Amino Acid Sequence; Animals; Antigens, Bacterial; Autoantibodies; Autoantigens; Bacteria; Biofilms; Biomarkers; Disease Models, Animal; Disease Progression; Disease Susceptibility; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Transgenic; Peptides; Terpenes | 2021 |
A
Topics: Adenosine; Animals; Autoimmunity; Diabetes Mellitus, Type 1; Disease Models, Animal; Extracellular Traps; Lupus Erythematosus, Systemic; Lymphopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Activation; Neutrophils; Receptor, Adenosine A1; Receptor, Adenosine A2A; RNA, Messenger; Signal Transduction; Streptozocin; Terpenes | 2021 |
Myxomavirus serpin alters macrophage function and prevents diffuse alveolar hemorrhage in pristane-induced lupus.
Topics: Animals; Blood Coagulation; Female; Hemorrhage; Interleukin-10; Kruppel-Like Factor 4; Liver X Receptors; Lung Diseases; Lupus Erythematosus, Systemic; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myxoma virus; RAW 264.7 Cells; Serpins; Terpenes; Viral Proteins | 2021 |
Dependence on Autophagy for Autoreactive Memory B Cells in the Development of Pristane-Induced Lupus.
Topics: Animals; Autoantibodies; Autoantigens; Autoimmunity; Autophagy; Disease Models, Animal; Lupus Erythematosus, Systemic; Memory B Cells; Mice; Mice, Inbred MRL lpr; Terpenes | 2021 |
Characterization of a PRISTANE-induced lupus-associated model in the non-human primate cynomolgus monkey.
Topics: Animals; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Macaca fascicularis; Terpenes; Ultrasonography | 2018 |
A Novel Subset of Anti-Inflammatory CD138
Topics: Animals; Antigens, Ly; Apoptosis; Bone Marrow Cells; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Humans; Inflammation; Interleukin-10 Receptor alpha Subunit; Lung; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Membrane Proteins; Mice; Mineral Oil; Phagocytosis; Poly I; Receptors, Immunologic; Spleen; Syndecan-1; Terpenes; Tumor Necrosis Factor-alpha | 2017 |
MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus.
Topics: Animals; Autoantibodies; Gene Expression Regulation; Interferons; Kidney; Lung; Lupus Erythematosus, Systemic; Mice; MicroRNAs; Nephritis; Pneumonia; T-Lymphocyte Subsets; Terpenes | 2017 |
[AMPK over-expression inhibits proliferation, matrix synthesis and inflammation response of glomerular mesangial cells in pristine-induced lupus mice].
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Autoantibodies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Extracellular Matrix; Inflammation Mediators; Lupus Erythematosus, Systemic; Male; Mesangial Cells; Mice, Inbred C57BL; Terpenes | 2017 |
Soluble MHC class II-driven therapy for a systemic lupus erythematosus murine experimental in vitro and in vivo model.
Topics: Animals; Antibodies, Antinuclear; Autoantigens; CD4 Antigens; Cells, Cultured; CTLA-4 Antigen; Disease Models, Animal; DNA; Histocompatibility Antigens Class II; Immune Tolerance; Immunosuppression Therapy; Immunotherapy; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes; Terpenes | 2018 |
Liver X Receptor Agonist Therapy Prevents Diffuse Alveolar Hemorrhage in Murine Lupus by Repolarizing Macrophages.
Topics: Animals; Cell Polarity; Disease Models, Animal; Hemorrhage; Humans; Hydrocarbons, Fluorinated; Hypoxia-Inducible Factor 1, alpha Subunit; Liver X Receptors; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Mice; Monocytes; Sulfonamides; Terpenes; Tumor Necrosis Factor-alpha | 2018 |
Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Topics: Animals; Arthritis; B-Lymphocytes; Disease Models, Animal; Female; Galectins; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Terpenes; Th1 Cells | 2018 |
Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus.
Topics: Animals; Cytokines; Disease Models, Animal; Erythropoietin; Female; Hematopoiesis; Inflammation; Kidney; Lupus Erythematosus, Systemic; Macrophage Activation; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Oligopeptides; Phagocytosis; RAW 264.7 Cells; Terpenes | 2018 |
Effect of active immunization with IL-17A on B cell function and infection risk in pristane-induced lupus model.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antinuclear; Antibodies, Neutralizing; B-Lymphocytes; Disease Models, Animal; Female; Hemocyanins; Immunization; Immunogenicity, Vaccine; Interleukin-17; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Staphylococcal Infections; Terpenes; Time Factors | 2018 |
Virgin olive oil and its phenol fraction modulate monocyte/macrophage functionality: a potential therapeutic strategy in the treatment of systemic lupus erythematosus.
Topics: Animals; Cytokines; Diet; Female; Humans; Immunity, Innate; Inflammation; Lipopolysaccharides; Lupus Erythematosus, Systemic; Macrophages; Macrophages, Peritoneal; Mice, Inbred BALB C; Monocytes; Nitric Oxide; Nitrites; Olea; Olive Oil; Phenol; Phenols; Plant Extracts; PPAR gamma; Terpenes; Toll-Like Receptor 4 | 2018 |
In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Topics: Animals; Disease Models, Animal; Humans; Immunity, Cellular; Inflammation; Interleukin-10; Interleukin-17; Lactobacillus; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Probiotics; T-Lymphocytes, Regulatory; Terpenes; Th1 Cells; Th17 Cells | 2018 |
IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.
Topics: Adult; Animals; Cell Line; Disease Models, Animal; Epithelium; Female; Gene Expression Regulation; Humans; Interleukin-16; Lung; Lupus Erythematosus, Systemic; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Middle Aged; Neutrophil Infiltration; Neutrophils; Pneumonia; Primary Cell Culture; Terpenes | 2018 |
Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation.
Topics: Animals; Blotting, Western; Cell Differentiation; Chemokine CXCL1; Chemokine CXCL2; Disease Models, Animal; Female; Flavonoids; Flavonols; Flow Cytometry; Interleukin-1beta; Interleukin-6; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; Terpenes; Th17 Cells; Tumor Necrosis Factor-alpha | 2018 |
Amelioration of regulatory T cells by Lactobacillus delbrueckii and Lactobacillus rhamnosus in pristane-induced lupus mice model.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Cell Proliferation; Creatinine; Cytokines; Disease Models, Animal; Female; Forkhead Transcription Factors; Granuloma; Kidney Function Tests; Lacticaseibacillus rhamnosus; Lactobacillus delbrueckii; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Probiotics; T-Lymphocytes, Regulatory; Terpenes; Urea | 2019 |
Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Cytokines; Disease Models, Animal; Disease Susceptibility; Female; Humans; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Phagocytosis; Receptors, IgG; Spleen; Terpenes; Th1 Cells | 2019 |
Galectin 9: Friend or Foe of Systemic Lupus Erythematosus? Comment on the Article by Zeggar et al.
Topics: Animals; Arthritis; Galectins; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Nephritis; Terpenes | 2019 |
LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
Topics: Animals; Antibody Formation; B-Lymphocytes; Case-Control Studies; Female; Germinal Center; Kidney; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice, Inbred C57BL; Plasma Cells; Severity of Illness Index; Terpenes; Up-Regulation | 2019 |
Examination of the role of sphingosine kinase 2 in a murine model of systemic lupus erythematosus.
Topics: Adolescent; Adult; Animals; Apoptosis; Ascitic Fluid; Gene Expression Regulation, Enzymologic; Humans; Lupus Erythematosus, Systemic; Lysophospholipids; Mice; Middle Aged; Peritoneal Lavage; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Terpenes; Young Adult | 2019 |
CD4
Topics: Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antigens, Ly; CD28 Antigens; CD4-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lipopolysaccharide Receptors; Lupus Erythematosus, Systemic; Lymphocyte Count; Mice; Mice, Inbred BALB C; Peritoneal Lavage; Spleen; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Terpenes | 2019 |
Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Topics: Animals; Autoantibodies; Cytokines; Enzyme-Linked Immunosorbent Assay; Enzyme-Linked Immunospot Assay; Flow Cytometry; HMGB1 Protein; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; Proteinuria; Terpenes; Toll-Like Receptor 2 | 2013 |
Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Disease Models, Animal; Disease Progression; Female; Granulocytes; Inflammation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Severity of Illness Index; Species Specificity; Terpenes; Time Factors | 2013 |
Overexpression of membrane-bound fas ligand (CD95L) exacerbates autoimmune disease and renal pathology in pristane-induced lupus.
Topics: Animals; Apoptosis; BALB 3T3 Cells; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; Flow Cytometry; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Reverse Transcriptase Polymerase Chain Reaction; Terpenes; Transcriptome | 2013 |
An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.
Topics: Animals; Autoantibodies; Caspase 1; Cytokines; Disease Models, Animal; Endothelium, Vascular; Glomerulonephritis; Immune Complex Diseases; Immunosuppressive Agents; Inflammasomes; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Mice, Knockout; Terpenes; Vascular Diseases; Vasodilation | 2014 |
Assessment of the translational value of mouse lupus models using clinically relevant biomarkers.
Topics: Animals; Arthritis, Experimental; Autoantibodies; Biomarkers; Disease Models, Animal; Female; Humans; Interferons; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred NZB; Oligonucleotide Array Sequence Analysis; Species Specificity; Terpenes; Translational Research, Biomedical | 2014 |
Induced murine models of systemic lupus erythematosus.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Graft vs Host Disease; Immunoglobulins; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Phenotype; Terpenes | 2014 |
Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model.
Topics: alpha-MSH; Animals; Antibodies, Antinuclear; Arthritis; Corticotropin-Releasing Hormone; Cytokines; Disease Models, Animal; Female; Immunoglobulin G; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mice; Nitric Oxide Synthase Type II; Receptor, Melanocortin, Type 1; Terpenes | 2014 |
IL-17 promotes murine lupus.
Topics: Animals; Autoantibodies; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Interleukin-17; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Mice, Inbred Strains; Mice, Knockout; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells | 2014 |
Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.
Topics: Acute-Phase Proteins; Animals; Autoantibodies; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunohistochemistry; Interleukin-12; Kidney; Lipocalin-2; Lipocalins; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proto-Oncogene Proteins; Spleen; Terpenes | 2014 |
Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.
Topics: Animals; Apoptosis; Autoantibodies; Dendritic Cells; Disease Models, Animal; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Neutrophils; Terpenes; Tumor Necrosis Factor-alpha | 2015 |
Pristane-induced granulocyte recruitment promotes phenotypic conversion of macrophages and protects against diffuse pulmonary hemorrhage in Mac-1 deficiency.
Topics: Animals; Antigens, Differentiation; Cell Movement; Gene Deletion; Gene Expression Regulation; Granulocytes; Hemorrhage; Interleukin-13; Interleukin-4; Lung; Lupus Erythematosus, Systemic; Macrophage-1 Antigen; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritoneal Cavity; Peritoneal Lavage; Phenotype; Severity of Illness Index; Signal Transduction; Terpenes | 2014 |
Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.
Topics: Acute Kidney Injury; Animals; Antibodies, Monoclonal; Antigens, CD20; Autoantibodies; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Cell Count; Disease Models, Animal; Female; Immunotherapy; Incidence; Interferon-alpha; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Terpenes; Treatment Outcome | 2015 |
BAFF regulates follicular helper t cells and affects their accumulation and interferon-γ production in autoimmunity.
Topics: Adult; Animals; Autoimmunity; B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Cell Maturation Antigen; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interferon-gamma; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Middle Aged; Real-Time Polymerase Chain Reaction; T-Lymphocytes, Helper-Inducer; Terpenes | 2015 |
Resveratrol possesses protective effects in a pristane-induced lupus mouse model.
Topics: Animals; Antigens, CD; Antigens, CD19; Antigens, Differentiation, T-Lymphocyte; Apoptosis; B-Lymphocytes; CD4-Positive T-Lymphocytes; Gene Expression Regulation; Humans; Inflammation; Lectins, C-Type; Lupus Erythematosus, Systemic; Mice; Receptors, Transferrin; Resveratrol; Sirtuin 1; Stilbenes; Terpenes | 2014 |
No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimicrobial Cationic Peptides; Arthritis, Experimental; Autoantibodies; Blood Cells; Cathelicidins; Chemokines; Cohort Studies; Disease Models, Animal; DNA; Female; Follow-Up Studies; Hemorrhage; Humans; Interferon-alpha; Longitudinal Studies; Lupus Erythematosus, Systemic; Male; Mice, Inbred C57BL; Middle Aged; Peritoneal Lavage; RNA; Terpenes; Young Adult | 2014 |
Caspase-1 is required for maintenance of marginal zone B cells in pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; B-Lymphocytes; Caspase 1; Cells, Cultured; Disease Models, Animal; Ficoll; Genetic Predisposition to Disease; Imidazoles; Immunization; Immunoglobulin G; Immunoglobulin M; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Knockout; Nitrophenols; Ovalbumin; Phenotype; Phenylacetates; Spleen; T-Lymphocytes; Terpenes; Time Factors | 2016 |
Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus.
Topics: Animals; Female; Immunoglobulins; Kidney Glomerulus; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Count; Mice; Peritonitis; Receptors, CCR6; STAT3 Transcription Factor; Survival Rate; T-Lymphocytes, Regulatory; Terpenes; Th17 Cells; Vasculitis | 2016 |
In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage.
Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Hemorrhage; Immunosuppressive Agents; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; NF-kappa B; Oligonucleotides; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Terpenes | 2016 |
Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
Topics: Adoptive Transfer; Animals; Antibodies; Antigens, Ly; CD11b Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Communication; Cell Proliferation; Dinoprostone; Disease Models, Animal; Female; Hemocyanins; Immunization; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Monocytes; Nitric Oxide; Spleen; Terpenes | 2016 |
Maintenance of autoantibody production in pristane-induced murine lupus.
Topics: Animals; Autoantibodies; Autoantigens; B-Lymphocyte Subsets; B-Lymphocytes; Cell Differentiation; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunologic Memory; Lupus Erythematosus, Systemic; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Plasma Cells; snRNP Core Proteins; Terpenes; Toll-Like Receptor 7 | 2015 |
C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus.
Topics: Animals; Arthritis; Autoantibodies; Chemokines; Complement C1q; Cytokines; Disease Models, Animal; Interferon Inducers; Interferon-alpha; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages, Peritoneal; Mice, Inbred BALB C; Monocytes; Poly I-C; Terpenes; Toll-Like Receptor 7 | 2016 |
Btk inhibition treats TLR7/IFN driven murine lupus.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Arthritis; Autoantibodies; Disease Models, Animal; Female; Foot Joints; Humans; Immunosuppressive Agents; Interferon Type I; Kidney; Lupus Erythematosus, Systemic; Macrophages; Male; Mice, Inbred C57BL; Mice, Inbred DBA; Nephritis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proteinuria; Terpenes; Toll-Like Receptor 7 | 2016 |
The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Chemokines; Disease Models, Animal; Female; Hepatitis B; Incidence; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Random Allocation; Terpenes | 2016 |
A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
Topics: Adult; Animals; Apoptosis; Autoantibodies; Case-Control Studies; CD18 Antigens; Complement C3; Complement C4; Complement Inactivating Agents; Complement System Proteins; Cytokines; Disease Models, Animal; Elapid Venoms; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Interferon Type I; Lupus Erythematosus, Systemic; Male; Middle Aged; Opsonin Proteins; Phagocytosis; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Terpenes | 2016 |
Psgl-1 Deficiency is Protective against Stroke in a Murine Model of Lupus.
Topics: Animals; Antibodies, Antinuclear; Brain; Disease Models, Animal; Female; Infarction, Middle Cerebral Artery; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Specific Pathogen-Free Organisms; Stroke; Terpenes | 2016 |
"Lupoid hepatitis" in SLE patients and mice with experimental lupus.
Topics: Actins; Adult; Aged; Animals; Autoantibodies; Disease Models, Animal; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver; Lupus Erythematosus, Systemic; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Muscle, Smooth; Serum Globulins; Terpenes; Young Adult | 2016 |
Establishing a tree shrew model of systemic lupus erythematosus and cell transplantation treatment.
Topics: Animals; Disease Models, Animal; Inflammation; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Terpenes; Tupaiidae; Umbilical Cord | 2016 |
Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.
Topics: Animals; Autoantibodies; Autoimmunity; Disease Models, Animal; Humans; Immunity, Innate; Inflammation; Leptin; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; T-Lymphocytes, Regulatory; Terpenes | 2016 |
Methyl salicylate 2-
Topics: Animals; Autoantibodies; Cytokines; Disease Progression; Female; Glycosides; Inflammation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Salicylates; Signal Transduction; Terpenes | 2016 |
Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus.
Topics: Animals; Antigen-Antibody Complex; Autoimmunity; Chemokines; Cytokines; Glomerulonephritis; Inflammation Mediators; Kidney; Lupus Erythematosus, Systemic; Mice; Myeloid Cells; Nephritis, Interstitial; NLR Family, Pyrin Domain-Containing 3 Protein; Terpenes | 2017 |
Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.
Topics: Animals; Disease Models, Animal; Female; Hemorrhage; Humans; Interleukin-10; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; Terpenes | 2017 |
Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Topics: Animals; Annexin A1; Apoptosis; Autoantibodies; Autoantigens; Autoimmunity; B-Lymphocytes; Biomarkers; Cytokines; Disease Management; Disease Models, Animal; Female; Immunization; Immunoglobulin G; Immunophenotyping; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Molecular Targeted Therapy; Spleen; T-Lymphocytes; Terpenes | 2017 |
Aconitine: A potential novel treatment for systemic lupus erythematosus.
Topics: Aconitine; Animals; Antibodies, Antinuclear; Cytokines; Dinoprostone; Disease Models, Animal; Female; Immunoglobulin G; Immunologic Factors; Kidney; Leukocyte Count; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Pilot Projects; Proliferating Cell Nuclear Antigen; Proteinuria; Spleen; Terpenes | 2017 |
TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus.
Topics: Animals; Autoantibodies; Cell Line; Female; Humans; Immunosuppressive Agents; Interferon Type I; Interleukin-6; Lupus Erythematosus, Systemic; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myeloid Differentiation Factor 88; Receptors, IgG; Ribonucleoproteins; Terpenes; Toll-Like Receptor 7 | 2008 |
B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.
Topics: Adipose Tissue; Animals; Autoantibodies; Autoantigens; B-Lymphocytes; Cell Proliferation; Choristoma; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Germinal Center; Immunoglobulin Class Switching; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoproteins, Small Nuclear; Somatic Hypermutation, Immunoglobulin; T-Lymphocytes; Terpenes | 2009 |
Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Autoantibodies; B-Lymphocyte Subsets; Crosses, Genetic; Disease Models, Animal; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Count; Lymphocyte Depletion; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NZB; Sialic Acid Binding Ig-like Lectin 2; Survival Rate; Terpenes | 2010 |
Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Topics: Animals; Autoimmunity; B-Lymphocytes; Cell Line; Cytokines; DNA; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, SCID; Rats; Receptors, Antigen, B-Cell; Receptors, IgG; Recombinant Fusion Proteins; Terpenes | 2010 |
Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.
Topics: Animals; Antibodies, Antinuclear; Cytokines; Disease Models, Animal; Female; Humans; Immunoglobulin M; Immunosuppressive Agents; Interleukin-13; Interleukin-2; Interleukin-6; Kidney; Lupus Erythematosus, Systemic; Male; Melatonin; Mice; Mice, Inbred BALB C; Terpenes | 2010 |
TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Topics: Animals; Autoantibodies; Autoimmunity; Cells, Cultured; Cytokines; Disease Models, Animal; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Knockout; Terpenes; Th1 Cells; Toll-Like Receptor 4; Toll-Like Receptor 9 | 2010 |
IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.
Topics: Adoptive Transfer; Animals; Bone Marrow; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; Cells, Cultured; Female; Flow Cytometry; Gene Expression; Germinal Center; Interleukins; Lupus Erythematosus, Systemic; Male; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cytokine; Receptors, Interleukin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; T-Lymphocytes, Helper-Inducer; Terpenes; Transplantation Chimera | 2010 |
[Study on experimental systemic lupus erythematosus mouse model induced by pristane].
Topics: Animals; Antigen-Antibody Complex; Arthritis; Autoantibodies; B-Lymphocytes; Disease Models, Animal; Female; Immunoglobulin G; Immunosuppressive Agents; Interferon-alpha; Kidney; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Spleen; Terpenes | 2011 |
Role of reactive intermediates in the immunopathogenesis of the pristane-induced Balb/c model of lupus.
Topics: Animals; Female; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitrites; Oxidative Stress; Reactive Oxygen Species; Terpenes | 2011 |
Therapeutic effect of Withania somnifera on pristane-induced model of SLE.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Cytokines; Disease Models, Animal; Female; Indomethacin; Kidney; Lupus Erythematosus, Systemic; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Phytotherapy; Plant Extracts; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; Terpenes; Withania | 2012 |
Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus.
Topics: Animals; Autoantibodies; B-Lymphocytes; Carcinogens; Cell Differentiation; Cell Movement; Cytokines; Dendritic Cells; Disease Models, Animal; Humans; Interferon Regulatory Factors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Knockout; T-Lymphocyte Subsets; Terpenes; Th1-Th2 Balance | 2012 |
Irf5-deficient mice are protected from pristane-induced lupus via increased Th2 cytokines and altered IgG class switching.
Topics: Animals; Autoantibodies; Autoimmunity; Cytokines; Immunoglobulin Class Switching; Immunoglobulin G; Interferon Regulatory Factors; Lupus Erythematosus, Systemic; Lymphocyte Activation; Mice; Mice, Inbred C57BL; T-Lymphocytes; Terpenes; Th2 Cells | 2012 |
Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils.
Topics: Alkanes; Animals; Apoptosis; Arthritis; Autoantibodies; Autoantigens; Cell Line; Glyburide; Humans; Hydrocarbons; Interferon Type I; Interleukin-1alpha; Interleukin-1beta; Lupus Erythematosus, Systemic; Lymph Nodes; Mice; Neutrophil Activation; Neutrophils; Potassium Channel Blockers; Rats; Terpenes | 2012 |
Monocytes from Irf5-/- mice have an intrinsic defect in their response to pristane-induced lupus.
Topics: Animals; Antigens, Ly; Cell Movement; HEK293 Cells; Humans; Interferon Regulatory Factors; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Peritoneal Cavity; Terpenes | 2012 |
Induction of lupus autoantibodies by adjuvants.
Topics: Adjuvants, Immunologic; Animals; Autoantibodies; Autoantigens; Cytokines; Female; Freund's Adjuvant; Immunoglobulin G; Interleukin-12; Lipids; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Peritoneum; Proteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; Squalene; Terpenes | 2003 |
X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Topics: Agammaglobulinemia; Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Cytokines; DEAD-box RNA Helicases; Disease Models, Animal; DNA, Single-Stranded; Enzyme-Linked Immunosorbent Assay; Genetic Diseases, X-Linked; Immunoglobulin G; Immunosuppressive Agents; Injections, Intraperitoneal; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred CBA; Neoplasm Proteins; RNA Helicases; Terpenes | 2003 |
Murine lupus induced by tetramethylpentadecane: an animal model of systemic human autoimmunity.
Topics: Animals; Disease Models, Animal; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Specific Pathogen-Free Organisms; Terpenes | 2005 |
Pristane-induced autoimmunity in germ-free mice.
Topics: Animals; Autoantibodies; Body Weight; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Granuloma; Histocytochemistry; Hypergammaglobulinemia; Liver; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Organ Size; Specific Pathogen-Free Organisms; Spleen; Statistics, Nonparametric; Terpenes | 2005 |
The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice.
Topics: Animals; Disease Models, Animal; Galactosylceramides; Immunosuppressive Agents; Killer Cells, Natural; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Terpenes | 2005 |
Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Topics: Animals; Autoantibodies; B-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Immunoglobulin G; Interleukin-6; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Receptors, IgG; Terpenes | 2005 |
Hypercatabolism of IgG in mice with lupus-like syndrome.
Topics: Animals; Base Sequence; Chickens; Disease Models, Animal; DNA, Complementary; Female; Gene Expression; Half-Life; Histocompatibility Antigens Class I; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Iodine Radioisotopes; Kinetics; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Receptors, Fc; Terpenes | 2005 |
Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus.
Topics: Animals; Apoptosis; Ascitic Fluid; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Injections, Intraperitoneal; Jurkat Cells; Lupus Erythematosus, Systemic; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Terpenes | 2005 |
Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).
Topics: Animals; Cell Line; Chemokine CXCL10; Chemokines; Chemokines, CXC; Choristoma; Cytokines; Dendritic Cells; Female; Granuloma; GTP-Binding Proteins; Interferon Regulatory Factor-7; Interferon Type I; Interleukin-12; Lupus Erythematosus, Systemic; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Mineral Oil; Myxovirus Resistance Proteins; Peritoneum; Terpenes; Ubiquitins | 2006 |
[Experimental study of pristane-induced murine lupus model].
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Disease Models, Animal; Female; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Terpenes | 2006 |
Endotoxin induces late increase in the production of pulmonary proinflammatory cytokines in murine lupus-like pristane-primed model [corrected].
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cells, Cultured; Cytokines; Disease Models, Animal; Endotoxins; Female; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lung; Lupus Erythematosus, Systemic; Mice; Mice, Inbred ICR; Terpenes; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
A female preponderance for chemically induced lupus in SJL/J mice.
Topics: Animals; Autoantibodies; Female; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Mice, Inbred Strains; Sex Factors; Terpenes | 2007 |
Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study.
Topics: Adult; Air Pollution, Indoor; Cluster Analysis; Cross-Sectional Studies; Diterpenes; Dust; Environmental Monitoring; Environmental Pollutants; Epidemiological Monitoring; Fatty Acids; Female; Hazardous Waste; Housing; Humans; Hydrocarbons; Industrial Waste; Lupus Erythematosus, Systemic; Lymphocyte Count; Male; Mercury; Metals; New Mexico; Petroleum; Sulfur Compounds; Terpenes | 2007 |
Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Topics: Animals; B-Lymphocytes; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Spleen; T-Lymphocytes; Terpenes; Thymus Gland | 2007 |
Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus.
Topics: Animals; Antibodies, Antinuclear; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Granuloma, Foreign-Body; Hemorrhage; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Lung; Lung Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Terpenes; Vasculitis | 2007 |
Deficiency of the type I interferon receptor protects mice from experimental lupus.
Topics: Animals; Autoantibodies; Disease Models, Animal; Female; Gene Expression; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoid Tissue; Male; Mice; Mice, Mutant Strains; Receptor, Interferon alpha-beta; Terpenes | 2007 |
Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies.
Topics: Animals; Antibodies, Antinuclear; Apoptosis; Autoimmune Diseases; Cells, Cultured; Chromatin; Deoxyribonucleases; Disease Models, Animal; DNA Fragmentation; Gamma Rays; Immunoglobulin G; Lipopolysaccharides; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Terpenes | 2007 |
A novel type I IFN-producing cell subset in murine lupus.
Topics: Animals; Antigens, Ly; Autoantibodies; Dendritic Cells; Interferon Type I; Lupus Erythematosus, Systemic; Mice; Monocytes; Terpenes | 2008 |
Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Concanavalin A; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Female; Indomethacin; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-6; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lymphocytes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nitric Oxide; Spleen; Terpenes; Thymus Gland; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.
Topics: Animals; Antibodies, Antinuclear; Autoantigens; Disease Models, Animal; DNA, Single-Stranded; Female; Glomerulonephritis; Histones; Immune Complex Diseases; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Proteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; Terpenes | 1995 |
Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.
Topics: Animals; Antibodies, Monoclonal; Antibody Formation; Antibody Specificity; Autoantibodies; Blotting, Western; Carcinogens; Cell Line; Chromatography, Affinity; Cysteine; Humans; L Cells; Leukemia, Erythroblastic, Acute; Lupus Erythematosus, Systemic; Methionine; Mice; Mice, Inbred BALB C; Ribonucleoprotein, U1 Small Nuclear; Ribonucleoprotein, U5 Small Nuclear; Sulfur Radioisotopes; Terpenes; Tumor Cells, Cultured | 1994 |
Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Chromatin; DNA, Single-Stranded; Female; Glomerulonephritis; Immune Complex Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Mice, Nude; Proteins; Ribonucleoproteins; Ribonucleoproteins, Small Nuclear; snRNP Core Proteins; T-Lymphocytes; Terpenes | 1999 |
Immunopathogenesis of environmentally induced lupus in mice.
Topics: Animals; Antigen-Antibody Complex; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Environmental Exposure; Female; Glomerulonephritis; Granuloma; Humans; Lupus Erythematosus, Systemic; Mercuric Chloride; Mice; Mice, Inbred BALB C; Terpenes | 1999 |
Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Autoimmune Diseases; Female; Genetic Predisposition to Disease; H-2 Antigens; Haplotypes; Housing, Animal; Humans; Immunoglobulin G; K562 Cells; Lupus Erythematosus, Systemic; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Peptide Fragments; Phosphoproteins; Ribosomal Proteins; Species Specificity; Terpenes | 2000 |
B cell subsets in pristane-induced autoimmunity.
Topics: Animals; Autoantibodies; Autoimmune Diseases; B-Lymphocyte Subsets; CD5 Antigens; Cell Lineage; Disease Models, Animal; Female; Genetic Predisposition to Disease; Immunoglobulin D; Immunoglobulin G; Immunoglobulin M; Injections, Intraperitoneal; Interferon-gamma; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Peritoneal Cavity; Specific Pathogen-Free Organisms; Spleen; Terpenes | 2000 |
Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000.
Topics: Adult; Aged; Animals; Autoantibodies; Colony-Stimulating Factors; Colorectal Neoplasms; Data Collection; Female; Health Education; Hepatitis C; Hepatitis C, Chronic; HIV Antibodies; HIV Infections; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred BALB C; Middle Aged; Minority Groups; Osteopetrosis; Rats; Risk Factors; Saliva; Sigmoidoscopy; Societies, Medical; Surveys and Questionnaires; Terpenes; Women's Health | 2001 |